2016
DOI: 10.1073/pnas.1616100114
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin

Abstract: Glioblastoma multiforme (GBM) is an intractable tumor despite therapeutic advances, principally because of its invasive properties. Radiation is a staple in therapeutic regimens, although cells surviving radiation can become more aggressive and invasive. Subtraction hybridization identified melanoma differentiation-associated gene 9 [MDA-9/Syntenin; syndecan-binding protein (SDCBP)] as a differentially regulated gene associated with aggressive cancer phenotypes in melanoma. MDA-9/Syntenin, a highly conserved d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
130
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
2
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 89 publications
(133 citation statements)
references
References 49 publications
(73 reference statements)
3
130
0
Order By: Relevance
“…Given that integrins play a crucial role in brain tumor infiltration 42 and GBM intratumor variability in integrin expressions 43 . New trials that aim to halt GBM recurrence by inhibiting radiation-induced invasion gains and signaling changes 11,44 , or kinase inhibitors 10 , could benefit from accounting for intra-and-intertumoral differences in single cell migration. Boxplots show spatial and intertumoral heterogeneity in cell area and cell elongation.…”
Section: Discussionmentioning
confidence: 99%
“…Given that integrins play a crucial role in brain tumor infiltration 42 and GBM intratumor variability in integrin expressions 43 . New trials that aim to halt GBM recurrence by inhibiting radiation-induced invasion gains and signaling changes 11,44 , or kinase inhibitors 10 , could benefit from accounting for intra-and-intertumoral differences in single cell migration. Boxplots show spatial and intertumoral heterogeneity in cell area and cell elongation.…”
Section: Discussionmentioning
confidence: 99%
“…The combination of 113B7 with radiotherapy produced significant effects in decreasing GBM invasion and enhanced survival. Together, these data suggest that an effective PDZ inhibitor can complement traditional radiotherapy to combat aggressive cancers, such as GBM (Kegelman et al, 2017).…”
Section: Pdz Domain Inhibitors In Cancermentioning
confidence: 84%
“…However, targeting lager fragments containing multiple PDZ domains, rather than an isolated PDZ domain, might provide the required specificity. Syntenin is a good example of this, where the 113B7 inhibitor targeted PDZ1 and the linker between PDZ1 and PDZ2, but not PDZ2 (Kegelman et al, 2017). This example suggests that the interfaces between PDZ domains and their adjacent domains might provide greater specificity than the isolated PDZ domain.…”
Section: Pdz Domain Inhibitors In Cystic Fibrosismentioning
confidence: 99%
“…An interesting possibility for inhibiting the NF-κB pathway in conjunction with proteasome inhibition is through inhibition of MDA-9/Syntenin, which has shown promise in preclinical studies in reducing the invasiveness of radiation-induced GBM in adults. 44 Targeting the MAPK pathway may also be an effective strategy given the frequent NF1 mutations in TIHGG; MEK inhibition is a therapeutic strategy of interest in HGG and was effective (trametinib) in both TIHGG derived cell lines 45, 46 .…”
Section: Discussionmentioning
confidence: 99%